Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro

---

Bilir A., Erguven M., Ermis E., Sencan M., YAZIHAN N.

JOURNAL OF GYNECOLOGIC ONCOLOGY, vol.22, no.4, pp.225-232, 2011 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 22 Issue: 4
• Publication Date: 2011
• Doi Number: 10.3802/jgo.2011.22.4.225
• Journal Name: JOURNAL OF GYNECOLOGIC ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.225-232
• Istanbul University Affiliated: Yes

Abstract

Objective: The aim of the study was to investigate whether lithium chloride and medroxyprogesterone acetate can potentiate the cytotoxicity of imatinib mesylate in human endometrial cancer in vitro and the effect of midkine in these therapies.